HR 5160 119th Congress
Stem Cell Therapeutic and Research Reauthorization Act of 2025
Open official Congress.gov recordSource-linked procedural record
Bill journey
This is a chronology, not a progress score. Politically.com does not classify stages or infer what comes next. Records sharing a date are grouped because not every source field supplies a time.
-
Introduction Congress.gov
Introduced
Introduced in the House.
Open bill recordOfficial action Congress.gov
Referred to the Subcommittee on Health.
Open bill recordOfficial action Congress.gov
Referred to the House Committee on Energy and Commerce.
Open bill recordOfficial action Congress.gov
Introduced in House
Open bill recordOfficial action Congress.gov
Introduced in House
Open bill recordText version Congress.gov
Introduced in House
A dated text-version record is available.
Open text record -
Official action Congress.gov
Forwarded by Subcommittee to Full Committee by Voice Vote.
Open bill recordOfficial action Congress.gov
Subcommittee Consideration and Mark-up Session Held
Open bill record -
Official action Congress.gov
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
Open bill recordOfficial action Congress.gov
Committee Consideration and Mark-up Session Held
Open bill record -
Official action Congress.gov
Placed on the Union Calendar, Calendar No. 629.
Open bill recordOfficial action Congress.gov
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
Open bill recordOfficial action Congress.gov
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724.
Open bill recordText version Congress.gov
Reported in House
A dated text-version record is available.
Open text record -
Text version Congress.gov
Engrossed in House
A dated text-version record is available.
Open text recordOfficial action Congress.gov · 3:09 pm UTC
Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
Open bill recordOfficial action Congress.gov · 3:09 pm UTC
Considered under suspension of the rules. (consideration: CR H4642-4643)
Open bill recordOfficial action Congress.gov · 3:09 pm UTC
DEBATE - The House proceeded with forty minutes of debate on H.R. 5160.
Open bill recordOfficial action Congress.gov · 3:20 pm UTC
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Open bill recordOfficial action Congress.gov · 3:20 pm UTC
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642)
Open bill recordOfficial action Congress.gov · 3:20 pm UTC
Motion to reconsider laid on the table Agreed to without objection.
Open bill record -
Official action Congress.gov
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.
Open bill recordText version Congress.gov
Placed on Calendar Senate
A dated text-version record is available.
Open text record
View the complete bill journey as an accessible table
| Date and time | Record | Official detail | Source |
|---|---|---|---|
| IntroductionIntroduced | Introduced in the House. | Congress.gov | |
| Official actionReferred to the Subcommittee on Health. | No additional detail supplied.Committee · House committee actions · Code H11000 | Congress.gov | |
| Official actionReferred to the House Committee on Energy and Commerce. | No additional detail supplied.IntroReferral · House floor actions · Code H11100 | Congress.gov | |
| Official actionIntroduced in House | No additional detail supplied.IntroReferral · Library of Congress · Code Intro-H | Congress.gov | |
| Official actionIntroduced in House | No additional detail supplied.IntroReferral · Library of Congress · Code 1000 | Congress.gov | |
| Text versionIntroduced in House | A dated text-version record is available. | Congress.gov | |
| Official actionForwarded by Subcommittee to Full Committee by Voice Vote. | No additional detail supplied.Committee · House committee actions · Code H23000 | Congress.gov | |
| Official actionSubcommittee Consideration and Mark-up Session Held | No additional detail supplied.Committee · House committee actions · Code H22000 | Congress.gov | |
| Official actionOrdered to be Reported (Amended) by the Yeas and Nays: 48 - 0. | No additional detail supplied.Committee · House committee actions · Code H19000 | Congress.gov | |
| Official actionCommittee Consideration and Mark-up Session Held | No additional detail supplied.Committee · House committee actions · Code H15001 | Congress.gov | |
| Official actionPlaced on the Union Calendar, Calendar No. 629. | No additional detail supplied.Calendars · House floor actions · Code H12410 | Congress.gov | |
| Official actionReported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724. | No additional detail supplied.Committee · House floor actions · Code H12200 | Congress.gov | |
| Official actionReported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-724. | No additional detail supplied.Committee · Library of Congress · Code 5000 | Congress.gov | |
| Text versionReported in House | A dated text-version record is available. | Congress.gov | |
| Text versionEngrossed in House | A dated text-version record is available. | Congress.gov | |
| Official actionMr. Guthrie moved to suspend the rules and pass the bill, as amended. | No additional detail supplied.Floor · House floor actions · Code H30300 | Congress.gov | |
| Official actionConsidered under suspension of the rules. (consideration: CR H4642-4643) | No additional detail supplied.Floor · House floor actions · Code H30000 | Congress.gov | |
| Official actionDEBATE - The House proceeded with forty minutes of debate on H.R. 5160. | No additional detail supplied.Floor · House floor actions · Code H8D000 | Congress.gov | |
| Official actionOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642) | No additional detail supplied.Floor · House floor actions · Code H37300 | Congress.gov | |
| Official actionPassed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4642) | No additional detail supplied.Floor · Library of Congress · Code 8000 | Congress.gov | |
| Official actionMotion to reconsider laid on the table Agreed to without objection. | No additional detail supplied.Floor · House floor actions · Code H38310 | Congress.gov | |
| Official actionReceived in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464. | No additional detail supplied.Calendars · Senate | Congress.gov | |
| Text versionPlaced on Calendar Senate | A dated text-version record is available. | Congress.gov |
House roll calls join only on matching Congress, legislation type, and number. Senate roll calls join only on matching source-supplied document type and number, not question text. Committee and related-measure relationships have no date in their relationship records and therefore are counted above but never placed on the chronology.
Congressional Research Service
CRS summary
Stem Cell Therapeutic and Research Reauthorization Act of 2025This bill reauthorizes through FY2031 and revises programs that help patients receive transplants of bone marrow or umbilical cord blood from biologically unrelated donors. These programs are administered by the Health Resources and Services Administration (HRSA).The bill reauthorizes the C.W. Bill Young Cell Transplantation Program. This program supports transplantation of bone marrow and cord blood by increasing the quantities of donations, providing processes for matching and distributing donated materials to patients, and providing related information and research.Also, the bill reauthorizes and revises the National Cord Blood Inventory program, through which HRSA contracts with qualified cord blood banks to collect and maintain a supply of high-quality units for transplantation through the C.W. Bill Young Cell Transplantation Program. The bill amends the inventory program by (1) changing the inventory goal from 150,000 units to a sufficient supply as determined by HRSA, (2) requiring HRSA to manage the size and composition of the inventory to maximize clinical utility and efficiency, and (3) defining high quality cord blood unit to mean a unit meeting current industry standards and the requirements of the Food and Drug Administration.
Official documents
Text versions
- Placed on Calendar SenateJul 21, 2026
- Engrossed in HouseJul 20, 2026
- Reported in HouseJul 2, 2026
- Introduced in HouseSep 4, 2025